Locate Therapeutics (Locate) is a regenerative medicine product development company which has developed TAOS™ (Tailored Orchestrated Signalling matrix); a patented polymer technology with multiple medical applications.
The TAOS™ matrix system is a world-first in tissue repair. It is a unique regenerative medicine platform that provides an optimal structure to support tissue repair, and can precisely accommodate and promote the actions of locally-applied drugs, and emergent biological and cell-based therapies. TAOS’ injectable particulate formulation is thermally-triggered to solidify into a space-filling open porous depot that supports tissue repair before degrading away.Locate has additional complementary technologies in cell therapy bioprocessing (RPMax; Reversible Porous Matrix for trypsin-free 3D cell culture) and intracellular delivery (IntraStem high-performance carrier peptide).
For further information please email firstname.lastname@example.org or call +44 (0)115 784 0041..
For more up-to-date news regarding Locate Therapeutics, please visit our Linked-In page.
Innovate UK Funding Award for Locate Therapeutics and The University of Nottingham
11th Feb 2016 – Locate Therapeutics Ltd ("Locate"), the regenerative medicine development company, and the School of Pharmacy at The University of Nottingham, have been awarded a grant from Innovate UK. Read More > >
Dixon, J.E., Osman, G., Morris, G.E., Markides, H., Rotherham, M., Bayoussef, Z., El Haj, A.J., Denning, C. and Shakesheff, K.M., 2016. Highly efficient delivery of functional cargoes by the synergistic effect of GAG binding motifs and cell-penetrating peptides. Proceedings of the National Academy of Sciences, 113(3), pp.E291-E299.